Modern Imaging Techniques in the Diagnosis and Management of Prostate Cancer

Modern Imaging Techniques in the Diagnosis and Management of Prostate Cancer

Multiparametric MRI (mpMRI) is being considered as a game-changer in prostate cancer treatment and management. Our prostate cancer panel of Mike Scott, Tony Crispino, Allen Edel and Joel Nowak is talking to Dr. Antonio Carlos Westphalen about the current roles of MRI and mpMRI in diagnosis and management of prostate cancer. The panel will touch upon current roles of older forms of bone scanning and CT as well as discuss the evolving roles of newer imaging techniques in the diagnosis and management of high risk and metastatic prostate cancer. Issues on access to high quality imaging and role of the expert uro-radiologist in diagnosis and management of prostate cancer are some of the other aspects that will be covered in this discussion.

Panelists

Talk Recorded on July 27, 2017, 8 p.m.   EST 622 8

Hear Talk Audio




  • Anonymous User July 28, 2017, 11:45 a.m.  US/Eastern

    What is the accuracy of an Axumin PET scan for a patient currently undergoing radiation treatment after surgical treatment failure?

  • Anonymous User July 27, 2017, 8:14 p.m.  US/Eastern

    If mp-mri suggests possible clinically significant disease in the anterior apex, would a transperineal biopsy provide an advantage over trus biopsy and can the transperineal biopsy be performed with mri fusion

  • Anonymous User July 27, 2017, 8:11 p.m.  US/Eastern

    What is the role of MRI in the ongoing management of anActive Surveillance patient? How frequently should an MRI be done with an AS patient given the known existence of "invisible" tumors?

  • July 27, 2017, 8:02 p.m.  US/Eastern

    How do you find a good radiologist capable of doing a good mp MRI scan of the prostate and interpretation?

  • Anonymous User July 27, 2017, 7:58 p.m.  US/Eastern

    Dealing with recurrent PCa with current PSA of about 0.7. Would a C11 Acetate scan (Phoenix Molecular Imaging) or a 68 PSMA PET scan (UCLA or UCSF) be most appropriate to figure out what is going on. Thanks.

  • Anonymous User July 27, 2017, 5:38 p.m.  US/Eastern

    Would it be unusual or surprising to sample a lesion identified pi-rads v.2 score of 4 with 3 biopsy cores finding 2 with benign tissue and 1 with 5% or less Gleason 3+3=6? Isn't the mp-MRI advantage in differentiating clinically significant disease from that which is not?

  • Anonymous User July 26, 2017, 8:20 a.m.  US/Eastern

    At the institution where I am being followed for Actuve Surveillance, 3T prostate MRI is now done without IV contrast. How does this affect diagnostic accuracy? If a lesion is identified, should the exam be repeated with IV contrast?

  • Anonymous User July 24, 2017, 3:26 p.m.  US/Eastern

    What are your thoughts on Abbreviated Biparametric Prostate MR Imaging for initial diagnosis? It appears that using this technique could be cost effective in initial screening while saving many men from unnecessary TRUS biopsies.